128 related articles for article (PubMed ID: 25731454)
1. [A case of Carboplatin and pemetrexed combination chemotherapy for synchronous double cancers of hepatocellular carcinoma and primary lung cancer].
Okamoto E; Sato J; Sema M; Hayasaka J; Watanabe A; Takagi K; Kusano-Kitazume A; Tamura A; Kondo M; Sakuranaka H; Ochi J; Hanada S; Tanaka M; Akita H; Tei S; Ichioka M; Shibayama T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2154-6. PubMed ID: 25731454
[TBL] [Abstract][Full Text] [Related]
2. Synchronous double primary lung cancers with different response to pemetrexed.
Umemura S; Yamane H; Yano T; Hoshika T; Shiote Y; Takigawa N; Suwaki T; Shirakawa A; Kamei H
Anticancer Drugs; 2011 Jun; 22(5):473-6. PubMed ID: 21346552
[TBL] [Abstract][Full Text] [Related]
3. Synchronous Primary Lung Adenocarcinoma and Hepatocellular Carcinoma Successfully Treated with a Combination of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel.
Egawa T; Masuzawa K; Nakayama S; Maeda I; Tsunematsu S; Suzuki Y; Suzuki Y
Intern Med; 2021 Oct; 60(20):3273-3277. PubMed ID: 33840693
[TBL] [Abstract][Full Text] [Related]
4. [A case of adenocarcinoma of the lung with malignant pleural effusion in elderly patient treated effectively by pemetrexed and carboplatin].
Tada A; Sakaguchi K; Kobayashi M; Kagoshima T; Yamazaki Y; Kamisawa O
Gan To Kagaku Ryoho; 2012 Mar; 39(3):425-7. PubMed ID: 22421772
[TBL] [Abstract][Full Text] [Related]
5. Subacute cutaneous lupus erythematosus associated with pemetrexed plus Carboplatin chemotherapy.
González García A; Sifuentes Giraldo WA; Grillo Fernández E; Zea Mendoza A
J Clin Rheumatol; 2014 Dec; 20(8):449-50. PubMed ID: 25417687
[No Abstract] [Full Text] [Related]
6. Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116.
Casey EM; Harb W; Bradford D; Bufill J; Nattam S; Patel J; Fisher W; Latz JE; Li X; Wu J; Hanna N
J Thorac Oncol; 2010 Nov; 5(11):1815-20. PubMed ID: 20881647
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
Rodrigues-Pereira J; Kim JH; Magallanes M; Lee DH; Wang J; Ganju V; Martínez-Barrera L; Barraclough H; van Kooten M; Orlando M
J Thorac Oncol; 2011 Nov; 6(11):1907-14. PubMed ID: 22005471
[TBL] [Abstract][Full Text] [Related]
8. [Clinical experience of the use of pemetrexed (PEM) combined with cisplatin (CDDP)/Carboplatin (CBDCA) followed by long-term maintenance PEM in patients with non-squamous non-small cell lung cancer].
Ishikura H; Kumihashi Y; Kimura S; Matsuoka Y; Matsumoto D
Gan To Kagaku Ryoho; 2014 May; 41(5):623-6. PubMed ID: 24917009
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of recurrent invasive mucinous adenocarcinoma of the lung showing marked responses to platinum-based chemotherapyregimens with pemetrexed and bevacizumab].
Koma Y; Nakashima N; Koyama M; Goto K; Yokota N; Kimura K; Matsumoto Y; Yoshida C; Matsuoka H; Masuya D; Yoshimatsu H; Suzuki Y
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1525-8. PubMed ID: 24231707
[TBL] [Abstract][Full Text] [Related]
10. A Case of Hepatic Portal Venous Gas in a Patient Treated with Pemetrexed and Carboplatin for Lung Cancer.
Kawaguchi Y; Fujita T; Hanaoka J; Hayashi K
Chemotherapy; 2014; 60(2):88-90. PubMed ID: 25720567
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation and pharmacokinetic study of carboplatin plus pemetrexed for elderly patients with advanced nonsquamous non-small-cell lung cancer: Kumamoto thoracic oncology study group trial 1002.
Sakata S; Sasaki J; Saeki S; Hamada A; Kishi H; Nakamura K; Tanaka H; Notsute D; Sato R; Saruwatari K; Iriki T; Akaike K; Fujii S; Hirosako S; Kohrogi H
Oncology; 2015; 88(4):201-7. PubMed ID: 25502447
[TBL] [Abstract][Full Text] [Related]
12. Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLC.
Strimpakos AS; Banerji U; Thavasu P; Tsilimagou A; Psyrri A; Syrigos KN
Oncology; 2015; 89(1):53-9. PubMed ID: 25766505
[TBL] [Abstract][Full Text] [Related]
13. [A case of lung cancer in an elderly patient with malignant pleural effusion and pneumothorax treated with carboplatin, pemetrexed, and bevacizumab].
Miyahara E; Itagaki T; Kuwahara M; Kameda A; Oue N
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1237-40. PubMed ID: 25335706
[TBL] [Abstract][Full Text] [Related]
14. [Case of pemetrexed-induced acute lung injury].
Sakamoto S; Kaburaki K; Sakaguchi S; Sano G; Sugino K; Isobe K; Shibuya K; Kurosaki A; Uekusa T; Homma S
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):415-20. PubMed ID: 19514505
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Schuette WH; Gröschel A; Sebastian M; Andreas S; Müller T; Schneller F; Guetz S; Eschbach C; Bohnet S; Leschinger MI; Reck M
Clin Lung Cancer; 2013 May; 14(3):215-23. PubMed ID: 23332288
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
Smit EF; Burgers SA; Biesma B; Smit HJ; Eppinga P; Dingemans AM; Joerger M; Schellens JH; Vincent A; van Zandwijk N; Groen HJ
J Clin Oncol; 2009 Apr; 27(12):2038-45. PubMed ID: 19307503
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
Socinski MA; Weissman C; Hart LL; Beck JT; Choksi JK; Hanson JP; Prager D; Monberg MJ; Ye Z; Obasaju CK
J Clin Oncol; 2006 Oct; 24(30):4840-7. PubMed ID: 17050869
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902.
Kim YH; Hirabayashi M; Togashi Y; Hirano K; Tomii K; Masago K; Kaneda T; Yoshimatsu H; Otsuka K; Mio T; Tomioka H; Suzuki Y; Mishima M
Cancer Chemother Pharmacol; 2012 Aug; 70(2):271-6. PubMed ID: 22752216
[TBL] [Abstract][Full Text] [Related]
19. A case report of synchronous small cell lung cancer and gastric cancer successfully treated with carboplatin.
Sano T; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Tamura T; Sakurai M; Takahashi H; Nakano H; Tajiri H
Jpn J Cancer Res; 1986 Aug; 77(8):790-8. PubMed ID: 3019977
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
